MedTrace Logo

ACAM2000® Myopericarditis Registry

NCT01395082 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2024-03-18

No results posted yet for this study

Summary

The purpose of this registry is to study the natural history of vaccination-related myocarditis and pericarditis and to assess possible risk factors for these conditions.

Primary Objective:

\- To document the natural history of confirmed, probable, suspected, and subclinical myocarditis and pericarditis (myopericarditis) following ACAM2000® vaccination.

Other Pre-defined Objective:

\- To look for potential predictive factors for the prognosis of myopericarditis following ACAM2000® vaccination.

Conditions

Sponsors & Collaborators

  • Emergent BioSolutions

    lead INDUSTRY

Principal Investigators

  • Medical Director · Emergent BioSolutions

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2019-02-04
Completion
2019-02-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01395082 on ClinicalTrials.gov